Cholinesterase Inhibitors for Alzheimer Disease [2] (multiple letters)

JAMA

Volumn 289, Issue 18, 2003, Pages 2359-2361

  Van Gool, Willem A ^a   Lemstra, Afina W ^a   Finucane, Thomas E ^b   Schneider, Lon S ^c   Lilienfeld, Sean ^d   Trinh, Nhi Ha ^e   Yaffe, Kristine ^f  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^e Massach usetts General Hospital   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; HEPTYLSTIGMINE TARTRATE; METRIFONATE; PHYSOSTIGMINE; RIVASTIGMINE; TACRINE; VELNACRINE;

ALZHEIMER DISEASE; BEHAVIOR DISORDER; CAREGIVER; CHOLINESTERASE INHIBITION; CLINICAL TRIAL; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; HUMAN; LETTER; MEDICAL DECISION MAKING; META ANALYSIS; NEUROPSYCHIATRY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; NOTE; TREATMENT OUTCOME; DAILY LIFE ACTIVITY;

ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; HUMANS; TREATMENT OUTCOME; ACTIVITIES OF DAILY LIVING; META-ANALYSIS;

EID: 0242676885     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.18.2359-a     Document Type: Letter

References (0)